Shaanxi Kanghui Pharm Co Ltd (603139) — Capital Reinvestment Ratio
Latest as of September 2025:
3.44x
Shaanxi Kanghui Pharm Co Ltd (603139) has a Capital Reinvestment Ratio of 3.44x as of September 2025, meaning it reinvests 3% of its operating cash flow (CN¥7.14 Million) in capital expenditures (CN¥24.57 Million). See Shaanxi Kanghui Pharm Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.44x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥7.14 Million
CNY
Capital Expenditures
CN¥24.57 Million
CNY
Data as of
Sep 2025
Most recent filing
Shaanxi Kanghui Pharm Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Shaanxi Kanghui Pharm Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Shaanxi Kanghui Pharm Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Shaanxi Kanghui Pharm Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see 603139 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.25x | CN¥37.29 Million | CN¥46.66 Million | ▼ -54.3% |
| 2022 | 2.74x | CN¥50.43 Million | CN¥138.13 Million | ▼ -93.0% |
| 2021 | 39.13x | CN¥7.42 Million | CN¥290.30 Million | ▲ +1295.1% |
| 2020 | 2.80x | CN¥93.72 Million | CN¥262.89 Million | ▲ +270.3% |
| 2019 | 0.76x | CN¥107.53 Million | CN¥81.45 Million | ▲ +750.0% |
| 2018 | 0.09x | CN¥62.64 Million | CN¥5.58 Million | ▲ +8.2% |
| 2017 | 0.08x | CN¥43.60 Million | CN¥3.59 Million | ▲ +22.9% |
| 2016 | 0.07x | CN¥71.72 Million | CN¥4.81 Million | ▼ -84.8% |
| 2015 | 0.44x | CN¥28.50 Million | CN¥12.60 Million | ▼ -48.0% |
| 2014 | 0.85x | CN¥22.72 Million | CN¥19.30 Million | ▼ -34.2% |
| 2013 | 1.29x | CN¥39.35 Million | CN¥50.77 Million | ▲ +86.3% |
| 2012 | 0.69x | CN¥16.12 Million | CN¥11.17 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow